Global Metagenomics Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Metagenomics Market size is expected to reach USD 10.22 Billion in 2034 from USD 3.20 Billion (2025) growing at a CAGR of 13.78% during 2026-2034.

The Global Metagenomics Market is witnessing rapid growth due to increasing adoption of next-generation sequencing technologies in research and diagnostics. Metagenomics enables the study of genetic material directly from environmental and clinical samples, offering insights into microbial diversity and disease mechanisms. Rising interest in microbiome research and infectious disease surveillance is significantly driving market expansion.

Major growth drivers include technological advancements in high-throughput sequencing platforms and bioinformatics tools. Expanding applications in agriculture, environmental monitoring, and drug discovery are further broadening the market scope. Additionally, increasing research funding and collaborations between academic institutions and biotechnology companies are accelerating innovation in metagenomics.

In the coming years, the market is expected to benefit from decreasing sequencing costs and improved data analysis capabilities. Growing focus on personalized medicine and microbiome-based therapeutics will likely create new growth avenues. Emerging economies are anticipated to increase investments in genomic research infrastructure, supporting sustained expansion of the global metagenomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Kits & Reagents
Sequencing & Data Analytics Services
Software

By Technology

Shotgun Sequencing
16S Sequencing
Whole Genome Sequencing
Others

By Workflow

Pre-sequencing
Sequencing
Data Analysis

By Application

Environmental
Clinical Diagnostics
Drug Discovery
Biotechnology
Food & Nutrition
Others

COMPANIES PROFILED

BioRad Laboratories Inc, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Novogene Co Ltd, Promega Corporation, QIAGEN NV, Takara Bio Inc, Oxford Nanopore Technologies plc, F HoffmannLa Roche Ltd
We can customise the report as per your requirements.

Product Code: VMR112114033

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL METAGENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Sequencing & Data Analytics Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METAGENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Technology
5.2. Shotgun Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. 16S Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Whole Genome Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METAGENOMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Workflow
6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METAGENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Application
7.2. Environmental Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.6. Food & Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL METAGENOMICS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Technology
- 8.2.3 By Workflow
- 8.2.4 By Application
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Technology
- 8.3.3 By Workflow
- 8.3.4 By Application
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Technology
- 8.4.3 By Workflow
- 8.4.4 By Application
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Technology
- 8.5.3 By Workflow
- 8.5.4 By Application
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Technology
- 8.6.3 By Workflow
- 8.6.4 By Application
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL METAGENOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Bio-Rad Laboratories Inc
- 10.2.2 Illumina Inc
- 10.2.3 PerkinElmer Inc
- 10.2.4 Thermo Fisher Scientific Inc
- 10.2.5 Novogene Co. Ltd
- 10.2.6 Promega Corporation
- 10.2.7 QIAGEN N.V
- 10.2.8 Takara Bio Inc
- 10.2.9 Oxford Nanopore Technologies Plc
- 10.2.10 F. Hoffmann-La Roche Ltd